#Doximity

@tropicalonrails.bsky.social

1 month ago

[ENG] ⚪ Silver Sponsors confirmed!
 
[PT-BR] ⚪️ Sponsors Silver confirmados!

monde.com.br/
www.saeloun.com/
www.doximity.com/
v360.io/

#TropicalOnRails #RubyOnRails #Monde #Saeloun #Doximity #V360

3 0 0 0

2rZiKKbOU3nTafniR2qMMSE0gwZ

@2rzikkbou3ntafnir2qmmse0gwz.activitypub.awakari.com.ap.brid.gy

5 months ago

The billion-dollar rivalry over 'ChatGPT for doctors' just got nastier with dueling lawsuits Doximity is countersuing hot healthcare startup OpenEvidence after OpenEvidence claimed in June Doximity tried to steal the startup's AI prompts.

#Tech #Healthcare #Startups #Law #exclusive #doximity #open-evidence #limited-synd

Origin | Interest | Match

0 0 0 0

SearchEngine

@searchengine.activitypub.awakari.com.ap.brid.gy

5 months ago

The billion-dollar rivalry over 'ChatGPT for doctors' just got nastier with dueling lawsuits Doximity is countersuing hot healthcare startup OpenEvidence after OpenEvidence claimed in June Doximity tried to steal the startup's AI prompts.

#Tech #Healthcare #Startups #Law #exclusive #doximity #open-evidence #limited-synd

Origin | Interest | Match

0 0 0 0

Healthcare IT Today

@healthcareittoday.com

6 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference #healthIT #Doximity #PathwayMedical
www.healthcareittoday.com/?p=2526107

0 0 0 0

LLMs

@llms.activitypub.awakari.com.ap.brid.gy

6 months ago

OpenAI taps Instagram and Doximity execs to lead its next AI healthcare push OpenAI wants to compete to sell directly to healthcare customers. It brought on digital health veteran Nate Gross to lead its commercial strategy.

#Tech #Healthcare #exclusive #openai #doximity

Origin | Interest | Match

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

7 months ago

DigitalOcean, Doximity, Freshworks, Braze, and Teradata Stocks Trade Up, What You Need To Know - Yahoo Finance DigitalOcean, Doximity, Freshworks, Braze, and Teradata Stocks Trade Up, What You Need To Know Yahoo Finance

Click Subscribe #Stocks #Investing #Finance #DigitalOcean #Doximity

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

8 months ago

BofA Securities raises Doximity stock price target on stable pharma budgets Investing.com - BofA Securities raised its price target on Doximity Inc (NYSE:DOCS) to $62.00 from $55.00 on Tuesday, while maintaining a Neutral rating on the healthcare technology company. The price target increase follows a New York City investor meeting with Doximity’s CFO Anna Bryson and Vice President of Investor Relations Perry Gold, where company executives discussed pharma budgets, artificial intelligence investments, proposed direct-to-consumer legislation, and platform usage trends. BofA Securities expressed increased confidence about the stability of pharmaceutical budgets through the end of 2025, noting growing optimism around Doximity’s opportunity to leverage artificial intelligence across its platform, while acknowledging these efforts are still in early stages. The research firm highlighted that Doximity is appropriately balancing margin stability with accretive investments, which contributed to the more positive outlook reflected in the higher price target. The new $62 price objective represents approximately 34 times calendar year 2025 enterprise value to EBITDA multiple, up from approximately 30 times previously, reflecting BofA’s "growing confidence in the business" despite maintaining caution on broader macroeconomic dynamics. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar?

Click Subscribe #Doximity #StockMarket #Investing #Pharma #Healthcare

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

9 months ago

BTIG upgrades Doximity saying pullback on macro fears overdone Investing.com -- BTIG upgraded Doximity Inc (NYSE:DOCS) to Buy from Neutral and set a price target of $80, saying recent macro concerns are overstated and demand for the company’s digital pharma sales tools remains strong. Doximity shares have fallen from a recent high of $83 to around $52, pressured by fears of drug pricing reform, potential U.S.-China trade tensions, and broader macro uncertainty. But BTIG said the company’s fundamentals remain intact and its guidance for fiscal 2026 is likely conservative. “Our view is that many of the concerns driving the recent pullback are overdone,” analysts wrote. DOCS has beaten consensus revenue and EBITDA in 16 of the past 16 quarters, and tends to guide conservatively. The firm pointed to Doximity’s trailing 12-month net revenue retention rate of 119%, including 123% among its top 20 clients, as a sign of strong customer engagement. It also cited a 92% gross margin, EBITDA margin of 55%, and a debt-free balance sheet with $900 million in cash. BTIG expects demand for targeted pharma sales technology to remain strong despite pressure on research-related services. The firm said recent results from peer Veeva showed the highest commercial revenue growth in three years, reinforcing the trend. Doximity’s self-service portal, which allows clients to directly manage campaign spending, was also highlighted as proof of high return on investment. Valuation-wise, DOCS trades at 21.7x estimated 2027 EBITDA, slightly above the peer average. BTIG’s $80 target implies 35x, which it said is justified by strong margins and high visibility in revenue. “The company is well -positioned to benefit from the bio -pharma recovery, and we expect demand for digital advertising solutions to pick back up,” BTIG added.

Click Subscribe #Doximity #BTIG #StockMarket #InvestmentNews #MarketTrends

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

Kuehn Law Investigates Doximity, Inc. for Potential Shareholder Injustice Kuehn Law is examining potential breaches of fiduciary duty by Doximity insiders, urging affected shareholders to participate in the legal process.

Kuehn Law Investigates Doximity, Inc. for Potential Shareholder Injustice #USA #New_York #Kuehn_Law #Shareholder_Rights #Doximity

0 0 0 0

William Niehaus, MD

@wnhausmd.bsky.social

10 months ago

Might I suggest casting a vote for @cuphysmed.bsky.social as a top #residency in the @doximity.bsky.social survey of PM&R programs?

🏔️ We’ve got the mountains, the mentorship, and a whole lot of mission-driven energy. 🏔️

www.doximity.com/surveys/best...

#PMR #MedTwitter #Physiatry #Doximity

3 1 0 0

Eaves

@joineaves.bsky.social

11 months ago

Terry Smith nailed his entry in #Doximity.

He's already up 34% on the position.

Doximity has crushed the last four earnings—gaining ~30% intraday after each report.

Sign up at eaves.ai to track Terry’s latest portfolio moves after Q1.

$DOCS

0 0 0 0

The Merchant Prince

@themerchantprince.bsky.social

1 year ago

The sector is expected to continue to evolve, with companies focusing on profitability and demonstrating the value of their digital health solutions.

#digitalhealth #healthtech #stocks #marketanalysis #investing #COVID19 #telehealth #weightloss #HimsAndHers #Doximity #Teladoc #GoodRx

1 0 0 0

KatieOverV

@katiekwonmd.bsky.social

5 years ago

Why is the #Doximity comments section dominated by rabid Covid deniers? I use their Dialer app but nothing else. Gross look at an ugly side of the profession.

0 0 0 0

Posts tagged #Doximity